Bioscience shares showed little movement Monday despitebroad gains in other market indexes. The AMEX BiotechnologyIndex gained 0.04 points to 151.41.

Mycogen Inc. gained $1.38 to $15 after the stock(NASDAQ:MYCO) was recommended by the Wall Street EdgeStockline, an investment advisory service.

Curative Technologies Inc. lost 38 cents to $11.63. On Friday,the company said the FDA had issued it a warning letterregarding procedures at its wound-care centers. Peter Drake,an analyst at Vector Securities International, on Mondayrepeated his "buy" rating on the company after concluding thatCurative (NASDAQ:CURE) was moving aggressively to comply."The receipt of this letter will not negatively impact thebusiness of the WCC network," Drake wrote.

(c) 1997 American Health Consultants. All rights reserved.